Skip to content
10-K

Annual Report

PEAK PHARMACEUTICALS, INC. RMHI

0001199835-22-000806

← back to feed
Filed
Dec 19, 2022 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Cash And Equivalents FY 2018 · Sep 30, 2018 $0
Operating Cash Flow restated FY 2018 · Sep 30, 2017 −$18.31K
Current Liabilities FY 2018 · Sep 30, 2017 $195.68K
Total Liabilities FY 2018 · Sep 30, 2017 $195.68K
Current Assets FY 2018 · Sep 30, 2017 $2.99K
Total Assets FY 2018 · Sep 30, 2017 $2.99K
Net Income FY 2018 · Sep 30, 2017 −$51.23K
Operating Income FY 2018 · Sep 30, 2017 −$44.99K
Stockholders Equity FY 2018 · Sep 30, 2016 −$141.46K